How Merck’s Decision Saved Millions of Lives in China
Merck & Co. Inc. (MRK), the largest U.S. pharmaceutical company, transferred its genetically engineered hepatitis B vaccine technology to China in 1989. This was the decision of its former president, Dr. Roy Vagelos, who oversaw 10 years of research to successfully develop the vaccine. In September 1989, Merck signed an agreement with China to transfer ...
